212 related articles for article (PubMed ID: 29637585)
21. [Viral factors influencing histological changes of HBeAg-negative chronic hepatitis B patients with persistently normal serum ALT levels].
Yang YH; Xie Q; Wang H; Zhou HJ; Gui HL; Cai W; Guo SM; Yu H; Guo Q
Zhonghua Gan Zang Bing Za Zhi; 2009 Jun; 17(6):434-9. PubMed ID: 19567022
[TBL] [Abstract][Full Text] [Related]
22. Precore/basal core promoter mutants quantification throughout phases of hepatitis B virus infection by Simpleprobe.
Tu WH; Lv Y; Zhang YM; Hou W; Wang JY; Zhang YJ; Liu HY; Zhu HX; Qin YL; Mao RC; Zhang JM
World J Gastroenterol; 2015 Jun; 21(21):6639-48. PubMed ID: 26074702
[TBL] [Abstract][Full Text] [Related]
23. Quantitative HBsAg levels do not identify hepatic fibrosis in HBeAg-negative chronic hepatitis B patients.
Ahmed FA; Bajaifar MS; Ahmed MA; Alalwan A; Sanai FA; Albeladi K; Aljumah AA; Sanai FM
Saudi J Gastroenterol; 2019; 25(5):286-292. PubMed ID: 31044750
[TBL] [Abstract][Full Text] [Related]
24. Predictive value of HBsAg quantification for determining the clinical course of genotype C HBeAg-negative carriers.
Park H; Lee JM; Seo JH; Kim HS; Ahn SH; Kim DY; Han KH; Chon CY; Park JY
Liver Int; 2012 May; 32(5):796-802. PubMed ID: 22128792
[TBL] [Abstract][Full Text] [Related]
25. Prevalence of hepatocarcinoma-related hepatitis B virus mutants in patients in grey zone of treatment.
Gil-García AI; Madejón A; Francisco-Recuero I; López-López A; Villafranca E; Romero M; García A; Olveira A; Mena R; Larrubia JR; García-Samaniego J
World J Gastroenterol; 2019 Oct; 25(38):5883-5896. PubMed ID: 31636479
[TBL] [Abstract][Full Text] [Related]
26. Clinical significance and evolution of core promoter and precore mutations in HBeAg-positive patients with HBV genotype B and C: a longitudinal study.
Chen CH; Lee CM; Hung CH; Hu TH; Wang JH; Wang JC; Lu SN; Changchien CS
Liver Int; 2007 Aug; 27(6):806-15. PubMed ID: 17617124
[TBL] [Abstract][Full Text] [Related]
27. Serum hepatitis B surface antigen and hepatitis B e antigen titers: disease phase influences correlation with viral load and intrahepatic hepatitis B virus markers.
Thompson AJ; Nguyen T; Iser D; Ayres A; Jackson K; Littlejohn M; Slavin J; Bowden S; Gane EJ; Abbott W; Lau GK; Lewin SR; Visvanathan K; Desmond PV; Locarnini SA
Hepatology; 2010 Jun; 51(6):1933-44. PubMed ID: 20512987
[TBL] [Abstract][Full Text] [Related]
28. [Can HBsAg levels guide to differentiate inactive HBsAg carriers from HBeAg negative chronic B hepatitis?].
Sayan M; Mutlu B; Erdoğan S; Meriç M; Willke A
Mikrobiyol Bul; 2007 Jan; 41(1):87-93. PubMed ID: 17427556
[TBL] [Abstract][Full Text] [Related]
29. Prediction of disease reactivation in asymptomatic hepatitis B e antigen-negative chronic hepatitis B patients using baseline serum measurements of HBsAg and HBV-DNA.
Martinot-Peignoux M; Lapalus M; Laouénan C; Lada O; Netto-Cardoso AC; Boyer N; Ripault MP; Carvalho-Filho R; Asselah T; Marcellin P
J Clin Virol; 2013 Oct; 58(2):401-7. PubMed ID: 24004660
[TBL] [Abstract][Full Text] [Related]
30. Core Promoter and Pre-Core Variants of the Hepatitis B Virus (HBV) Are Frequent in Chronic Hepatitis B HBeAg-Negative Patients Infected by Genotypes A and D.
Reuter T; Gomes-Gouvea MS; Chuffi S; Duque UH; Perini W; Azevedo RS; Pinho JRR
Viruses; 2023 Nov; 15(12):. PubMed ID: 38140580
[TBL] [Abstract][Full Text] [Related]
31. Prevalence of mutations in basal core promoter and precore region of hepatitis B virus in vaccinated and nonvaccinated individuals of the aboriginal Nicobarese tribe of Car Nicobar Island, India.
Bhattacharya H; Bhattacharya D; Nagarajan M; Reesu R; Roy S; Attayur PS
Intervirology; 2014; 57(6):357-64. PubMed ID: 25323975
[TBL] [Abstract][Full Text] [Related]
32. Divergent preS Sequences in Virion-Associated Hepatitis B Virus Genomes and Subviral HBV Surface Antigen Particles From HBV e Antigen-Negative Patients.
Peiffer KH; Kuhnhenn L; Jiang B; Mondorf A; Vermehren J; Knop V; Susser S; Walter D; Dietz J; Carra G; Finkelmeier F; Zeuzem S; Sarrazin C; Hildt E
J Infect Dis; 2018 Jun; 218(1):114-123. PubMed ID: 29528436
[TBL] [Abstract][Full Text] [Related]
33. Quantitation of HBsAg predicts response to entecavir therapy in HBV genotype C patients.
Orito E; Fujiwara K; Kanie H; Ban T; Yamada T; Hayashi K
World J Gastroenterol; 2012 Oct; 18(39):5570-5. PubMed ID: 23112549
[TBL] [Abstract][Full Text] [Related]
34. Clinical Features of Chronic Hepatitis B in Treatment-naive Asian Patients With Positive HBeAg and Coexisting Precore and/or Basal Core Promoter Mutations.
Pan CQ; Dai E; Bhamidimarri KR; Zeng Z; Yin P
J Clin Gastroenterol; 2017 Mar; 51(3):261-267. PubMed ID: 27552328
[TBL] [Abstract][Full Text] [Related]
35. Role of HBsAg decline in patients with chronic hepatitis B HBeAg-negative and E genotype treated with pegylated-interferon.
Boglione L; Cusato J; Cariti G; Di Perri G; D'Avolio A
Antiviral Res; 2016 Dec; 136():32-36. PubMed ID: 27793564
[TBL] [Abstract][Full Text] [Related]
36. Precore and basal core promoter mutations in Asian American patients with hepatitis B e antigen-positive chronic hepatitis B.
Vutien P; Trinh HN; Nguyen K; Garcia RT; Nguyen HA; Levitt BS; Nguyen L; Ha NB; Ahmed A; Daugherty T; Garcia G; Nguyen MH
Aliment Pharmacol Ther; 2013 Feb; 37(4):464-72. PubMed ID: 23278246
[TBL] [Abstract][Full Text] [Related]
37. Precore and Basal Core Promoter Hepatitis B Virus (HBV) Variants Are Present From a Young Age and Differ Across HBV Genotypes.
Lau DTY; Ganova-Raeva L; Wang J; Mogul D; Chung RT; Lisker-Melman M; Chang KM; Shaikh OS; Janssen HLA; Wahed AS; Lok AS;
Hepatology; 2021 May; 73(5):1637-1651. PubMed ID: 32860463
[TBL] [Abstract][Full Text] [Related]
38. Low pretreatment serum HBsAg level and viral mutations as predictors of response to PEG-interferon alpha-2b therapy in chronic hepatitis B.
Tangkijvanich P; Komolmit P; Mahachai V; Sa-nguanmoo P; Theamboonlers A; Poovorawan Y
J Clin Virol; 2009 Oct; 46(2):117-23. PubMed ID: 19651540
[TBL] [Abstract][Full Text] [Related]
39. [Correlation between serum HBV DNA level and HBsAg titer in HBeAg-positive pregnant women and impact of genomic variability of hepatitis B virus pre S/S regions on their correlations].
Zhang X; Yan L; Lu Y; Wei KP; Liu ZX; Xiao YW; Ding F; Zhuang H; Li J
Zhonghua Gan Zang Bing Za Zhi; 2018 Aug; 26(8):579-584. PubMed ID: 30317788
[No Abstract] [Full Text] [Related]
40. Community-based epidemiology of hepatitis B virus infection in West Bengal, India: prevalence of hepatitis B e antigen-negative infection and associated viral variants.
Chowdhury A; Santra A; Chakravorty R; Banerji A; Pal S; Dhali GK; Datta S; Banerji S; Manna B; Chowdhury SR; Bhattacharya SK; Mazumder DG
J Gastroenterol Hepatol; 2005 Nov; 20(11):1712-20. PubMed ID: 16246191
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
